Glasgow, United Kingdom · Founded 2016 · Privately Held (backing)
Developer of a liquid biopsy-based cancer diagnostics platform designed for the early detection of multiple cancer types. Dxcover is based in Glasgow, United Kingdom and was founded in 2016. Its last reported valuation was $37.8 million in Jan 2025. It has raised $21.8 million.
Last reported valuation
$37.8M
Oct 2026
Priced at
—
Total raised
$21.8M
Last round
—
Cap table — not yet on record
Dxcover's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dxcover with a free account
·The complete investor list: 24 names
·Watch Dxcover: the Monday email on marks, rounds and moves
